Preferred Name | Maraviroc | |
Synonyms |
|
|
Definitions |
A C-C Chemokine Receptor Type 5 (CCR5) antagonist with activity against human immunodeficiency virus (HIV). Maraviroc inhibits HIV-1 entry via CCR5 coreceptor interaction. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C73144 |
|
CAS_Registry |
376348-65-1 |
|
CHEBI_ID |
CHEBI:63608 |
|
Chemical_Formula |
C29H41F2N5O |
|
code |
C73144 |
|
Contributing_Source |
CTRP FDA |
|
definition |
A C-C Chemokine Receptor Type 5 (CCR5) antagonist with activity against human immunodeficiency virus (HIV). Maraviroc inhibits HIV-1 entry via CCR5 coreceptor interaction. |
|
Display_Name |
Maraviroc |
|
FDA_UNII_Code |
MD6P741W8A |
|
Has_Target | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C173383 http://purl.obolibrary.org/obo/NCIT_C173381 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
label |
Maraviroc |
|
Legacy Concept Name |
Maraviroc |
|
NCI_Drug_Dictionary_ID |
696304 |
|
PDQ_Closed_Trial_Search_ID |
696304 |
|
PDQ_Open_Trial_Search_ID |
696304 |
|
Preferred_Name |
Maraviroc |
|
prefixIRI |
NCIT:C73144 |
|
prefLabel |
Maraviroc |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C1667052 |
|
subClassOf |
Create mapping